Skip to content
Search AI Powered
Human content, AI powered search.

Latest Stories

VA Rejects New Cannabis Research Bill For Veterans, Calls It 'Redundant'

Does the VA know what its doing on cannabis policy?
Does the VA know what its doing on cannabis policy?
Photo by Jessica Radanavong on Unsplash
Bluntness Editorial
By Bluntness EditorialJun 29, 2021
Bluntness Editorial
The Bluntness Editorial Staff is dedicated to bring you the many stories of cannabis culture - stories that speak to the enthusiast and expert in an unfiltered but factual manner. Everyday, our writers brings you deeply insightful and honest perspectives from all corners of the cannabis world, including some you may not expect.
See Full Bio
Follow:

This article was originally published by Nina Zdinjak on Benzinga and appears here with permission.

The Senate Veterans’ Affairs Committee reviewed a bill that would ask the U.S. Department of Veterans Affairs (VA) to run clinical trials on the potential benefits of cannabis for the treatment of military veterans suffering from post-traumatic stress disorder (PTSD) and chronic pain. 

The measure, sponsored by chairman Jon Tester (D-MT) and Sen. Dan Sullivan (R-AK), was discussed along with another 20 veteran-related bills although only the cannabis measure was not openly discussed but rather received written testimony opposing it, reported Marijuana Moment. 

Is The VA Against Cannabis Research For Veterans? 

Although VA Acting Deputy Under Secretary of Health for Community Care Mark Upton said the agency does not support this proposed legislation, it is not against cannabis research for veterans in general. 

Nevertheless, the VA seems to find the new legislation to be redundant and therefore unnecessary. 

As stated in testimony: “The proposed legislation is redundant to the extent that VA is already examining risks and benefits of cannabis in treating PTSD and chronic pain. For these reasons, VA does not support this proposed legislation.”

The agency also specifically argued against the provision that would require it to study “at least seven types of cannabis,” a task the VA finds inconsistent with "the current state of scientific evidence, which suggests that smaller, early phase, controlled clinical trials with a focused set of specific aims are optimal to determine proof of concept for use of cannabis in treating specific conditions.”

Upton wrote that the VA continues to research existing clinical evidence on the medical benefits of cannabis and acknowledges that more research is necessary.

 “VA has utilized the scientific peer review system and is currently supporting a clinical trial of CBD to treat PTSD where CBD is used as an add-on treatment to standard of care psychotherapy. The results from this study should be available next year,” Upton wrote.

Need a little more Bluntness in your life? Check out our YouTube page! 

The Latest

Comprehensive Glossary of Cannabis Terminology - The Bluntness
News

Cannabis Glossary: 120+ Terms

A classic case of botrytis a.k.a bud rot. Moldy cannabis should never be inhaled or smoked.
Wellness

Moldy Weed = Health Risk!

Are you paying too much attention to THC percentage? - The Bluntness
Wellness

High-THC: Is % Important?

More For You

protesters holding sign, peaceful, democracy

The Proposed Hemp Ban That Would Destroy a $28 Billion Success Story - The Bluntness

Photo by Leo_Visions on Unsplash

Hemp Ban Threatens $28B Industry

Congressional negotiators are trying to bury a hemp definition change in appropriations language, a backdoor maneuver that would treat nearly any THC in hemp-derived products as federally illegal. This is happening in real time, behind closed doors, without public hearings.

Sen. Rand Paul has pledged to hold up spending bills to stop this ban, but he's issued a stark warning: there's a "real danger" the prohibitionists win unless constituents flood Congress with calls immediately.

Keep ReadingShow less
image of California coast, pacific coast highway at sunset
How Overregulation Crushed California’s Gold Flora—And Why Other States Should Be Worried
Photo by Matthew Hamilton on Unsplash

Overregulation Kills Gold Flora

When California-based Gold Flora entered the legal cannabis scene, the company was poised to dominate. Backed by serious money and a sprawling, vertically integrated operation—from a 100,000-square-foot cultivation campus in the desert to marquee dispensaries in West Hollywood and San Jose—Gold Flora wasn't just riding the green wave. It was supposed to be the wave.

But by the end of March 2025, the company had filed for receivership, its assets now headed to auction. And while headlines cite "merger woes" and "market conditions," the real culprit behind Gold Flora’s collapse is far more systemic: a regulatory stranglehold that has quietly choked the life out of California’s once-promising cannabis economy.

Keep ReadingShow less
Kanye West Is Spiraling—And Our Mental Health System Is Letting It Happen - The Bluntness
Kanye West Is Spiraling—And Our Mental Health System Is Letting It Happen - The Bluntness
Photo by Axel Antas-Bergkvist on Unsplash

Kanye West Is Spiraling—And Our Mental Health System Is Letting It Happen - The Bluntness

Kanye West, aka Ye, isn’t just trending—he’s unraveling in real time. And instead of intervention, we get viral clips, condemnation, and an audience watching a man self-destruct. His latest stunt? Airing a Super Bowl ad promoting a swastika-emblazoned Yeezy shirt on his site—a move so blatantly antisemitic that even the most die-hard supporters had to step back. This act garnered significant media coverage, leading to brands cutting ties and agents dropping him. His social media account faced scrutiny and was ultimately deleted after a history of controversial postings. But here’s the problem: canceling Kanye doesn’t fix Kanye.

At this point, the question isn’t whether his actions are inexcusable (they are). The question is, what happens when one of the world’s most influential figures is also one of the most untreated cases of mental illness in pop culture history?

Keep ReadingShow less
Actor/Comedian Awkwafina smoking a joint held with chopsticks
Getting high w/ Awkwafina
Giphy

4/20: The Evolution of a Cultural Phenomenon


From countercultural whisper to mainstream celebration, the journey of April 20th—known simply as “4/20”—represents one of the most fascinating cultural shifts of our time. A decade ago, large gatherings at places like the University of Colorado Boulder were common, but administrative bans have since changed the landscape of 4/20 celebrations significantly. What began as coded communication among a small group of California teenagers has transformed into a global phenomenon that transcends its origins, reshaping attitudes, commerce, and policy along the way. While most things die within a couple years, '420' has persisted and grown in popularity, highlighting its sustained relevance and cultural significance among cannabis enthusiasts.

Keep ReadingShow less
retail shelves stocked with legal cannabis products
The mix of in-state and out of state brands at a legal NY dispensary
The mix of in-state and out of state brands at a legal NY dispensary

NY's Pot Industry: Wins, Woes, Next

Two years into New York's adult-use cannabis rollout, the state's Office of Cannabis Management (OCM) has dropped its most comprehensive look yet at the market's performance, challenges, and opportunities. The 2024 OCM Market Report is packed with impressive numbers and lofty intentions, but peel back the layers and a more complicated story unfolds—one where equity goals face harsh economic headwinds, regulatory delays hamper progress, and a persistent illicit market looms large.

Here's what you need to know:

Keep ReadingShow less